Tag: Itamar Medical
ZOLL, Itamar merge to advance link between cardiology, sleep apnea
September 14, 2021HME News Staff
CHELMSFORD, Mass., and CAESAREA, Israel – ZOLL Medical Corp. has signed a definitive agreement to acquire all outstanding ordinary shares of Itamar Medical for about $538 million.
Itamar Medical is focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory disorders, including the WatchPAT Home Sleep Apnea Device.
“It is currently estimated that 60% of cardiovascular patients suffer from some...
Itamar enhances WatchPAT
June 15, 2021HME News Staff
CAESAREA, Israel – Itamar Medical has enhanced its WatchPAT product line to include WatchPAT with SleepPath, a new service that allows subjective data to be collected from patients through the WatchPAT smartphone app, before and after the home sleep test. The company will offer the new service to sleep clinics, giving them access to digital documentation in one report that combines sleep study metrics and patient self-reported data, replacing traditional paper documentation. Itamar Medical...
HSAT trumps PSG, survey finds
April 13, 2021HME News Staff
CAESAREA, Israel – Ninety-three percent of health care professionals currently use home sleep apnea testing in their practices, according to the results of a recent survey designed by Itamar Medical.
Furthermore, HSAT represents more than 50% of the daily test volume in 66% of the practices surveyed.
“While sleep apnea affects an estimated 54 million to 64 million people in the U.S., roughly 80% of sufferers remain undiagnosed and untreated, largely due to the lack of...
Itamar on the HST boom
April 8, 2021Liz Beaulieu, Editor
ATLANTA – Itamar Medical’s Joao Mendes-Roter believes there’s a “digital revolution” happening in the home right now that will increase the percentage of sleep tests being conducted there in the long term.
The percentage of sleep tests conducted in homes vs. in labs has flip flopped from 30%/70% before the pandemic to 70%/30% during the pandemic, says Mendes-Roter, vice president of digital health marketing for Itamar, which makes the WatchPAT ONE home sleep test.
“We...
Itamar seeks to raise awareness of home sleep testing
February 16, 2021HME News Staff
ATLANTA – Eighty-nine percent of respondents to a survey commissioned by Itamar Medical say they know what sleep apnea is, but a deeper dive of results shows their understanding is “superficial.” The survey suggests a lack of awareness around the availability of safe and home-based diagnostic options, as well as a distrust of the data collected by commercially available wearable devices. “While unfortunately not all that surprising, the results of the survey exemplify the...
Itamar Medical ‘jump starts’ RPM initiatives with Spry Health acquisition
January 14, 2021HME News Staff
CAESAREA, Israel – Digital health company Itamar Medical plans to buy San Francisco-based Spry Health, which makes a wrist-based remote monitoring solution.
Spry’s Loop System, a watch-like, home-based device, uses sensing technologies and algorithms that contextualize real-time, continuous physiologic data to flag signs of patient deterioration using bio-markers such as SpO2, respiration rate and heart rate. These three signals, combined...
Itamar names president for US market
October 20, 2020HME News Staff
CAESAREA, Israel - Itamar Medical has appointed Shane Brown as president-U.S. effective immediately. In this role, he will oversee commercial strategy and execution in the U.S. as the company plans to further accelerate its investment in penetrating that market. Brown brings more than 20 years of commercial experience to the position, including leading the early adoption of emerging therapies in the medical device, digital health and medtech markets. Most recently, he served as vice president, enterprise...
Aeroflow partners with Itamar to expand sleep apnea solutions
April 23, 2020HME News Staff
ASHEVILLE, N.C. - Aeroflow Healthcare has contracted with Itamar Medical to add telemedicine services to its sleep apnea solutions. The relationship will increase patient access to home sleep testing using Itamar's WatchPAT ONE single-use device. “COVID-19 may impact patients' access to critical medical services, but Aeroflow Healthcare is committed to helping them stay safe and healthy by remaining fully operational and providing telehealth sleep therapy services," said Eric Mongeau,...
Itamar's WatchPAT gets nod from Blues
November 6, 2019HME News Staff
CAESAREA, Israel - Itamar Medical has received coverage for its WatchPAT as a home sleep apnea diagnostic test by Blue Shield of California (BSC) and the Blue Cross Blue Shield Federal Employee Plan (BCBS FEP). The inclusion of WatchPAT and PAT technology follows an assessment, Diagnosis and Medical Management of Obstructive Sleep Apnea Syndrome, recently released by Blue Cross Blue Shield Association Evidence Street. “The inclusion of WatchPAT as a recommended test for sleep apnea in the BCBS...
Itamar Medical: New fee schedule advances WatchPAT
November 16, 2018HME News Staff
CAESAREA, Israel - The recently released 2019 fee schedule from CMS should support broad use of Itamar Medical's WatchPAT technology, the company says. WatchPAT uses peripheral arterial tone (PAT) technology to provide cardiologists and sleep physicians in the United States with accurate sleep diagnoses. “We believe that the new CMS fee schedule validates the clinical value of our sleep tests for patients and may significantly advance utilization of our sleep tests in the U.S. market,”...